Cortical and subcortical gamma amino acid butyric acid deficits in anxiety and stress disorders: Clinical implications
Open Access
- 1 January 2016
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Psychiatry
- Vol. 6 (1) , 43-53
Abstract
Cortical and subcortical gamma amino acid butyric acid deficits in anxiety and stress disorders: Clinical implicationsKeywords
This publication has 79 references indexed in Scilit:
- Anxioselective anxiolytics: on a quest for the Holy GrailTrends in Pharmacological Sciences, 2012
- Prevalence, Persistence, and Sociodemographic Correlates of DSM-IV Disorders in the National Comorbidity Survey Replication Adolescent SupplementArchives of General Psychiatry, 2012
- Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypesNature Reviews Drug Discovery, 2011
- Altered GABA transmission in a mouse model of increased trait anxietyNeuroscience, 2011
- A key role for orexin in panic anxietyNature Medicine, 2009
- Association study between GABA receptor genes and anxiety spectrum disordersDepression and Anxiety, 2009
- Prefrontal Cortical Gamma-Aminobutyric Acid Levels in Panic Disorder Determined by Proton Magnetic Resonance SpectroscopyBiological Psychiatry, 2009
- Altered Cerebral γ-Aminobutyric Acid Type A–Benzodiazepine Receptor Binding in Panic Disorder Determined by [11C]Flumazenil Positron Emission TomographyArchives of General Psychiatry, 2008
- The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disordersJournal of Neural Transmission, 2008
- Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005